(Q46665887)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118251%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Alterations in liver, muscle, and adipose tissue insulin sensitivity in men with HIV infection and dyslipidemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118251%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118251%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Luigi Fontana

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118251%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Bruce W. Patterson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118251%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

William G Powderly

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118251%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

D N Reeds

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118251%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

W T Cade

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118251%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

E Laciny

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118251%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

A DeMoss

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118251%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

S Klein

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118251%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

23 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118251%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Endocrinology and Metabolism

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118251%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

290

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118251%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118251%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

E47-E53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118251%20AND%20SRC:MED&resulttype=core&format=json

An open-label, prospective, observational study of the incidence of coronary artery disease in patients with hiv infection receiving highly active antiretroviral therapy

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Mechanism of highly active anti-retroviral therapy-induced hyperlipidemia in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

An objective case definition of lipodystrophy in HIV-infected adults: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

An objective lipodystrophy severity grading scale derived from the lipodystrophy case definition score

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

The triglyceride issue: a view from Framingham

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Plasma triglyceride level and mortality from coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

The theoretical bases of indirect calorimetry: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Combination antiretroviral therapy and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Coronary heart disease in high-risk populations: lessons from Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Immunoassay of insulin with insulin-antibody precipitate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Buffalo hump seen in HIV-associated lipodystrophy is associated with hyperinsulinemia but not dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Risk of metabolic abnormalities in patients infected with HIV receiving antiretroviral therapy that contains lopinavir-ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Serum true insulin concentration and the risk of clinical non-insulin dependent diabetes during long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Effect of isoprenaline on plasma leptin and lipolysis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Alterations in lipid kinetics in men with HIV-dyslipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Metabolic basis of HIV-lipodystrophy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

CD36 deficiency induced by antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Lack of association between dyslipidemia and insulin resistance in HIV-infected persons treated with highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Interleukin-6 stimulates lipolysis and fat oxidation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005

Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00236.2005